We use cookies on our website. By continuing to browse our site, you are agreeing to our use of cookies. Find out more about our cookies Hide

GlaxoSmithKline PLC investigation

27 May, 2014 | News Releases

The Director of the SFO has opened a criminal investigation into the commercial practices of GlaxoSmithKline plc and its subsidiaries.

Whistleblowers are valuable sources of information to the SFO in its cases. We welcome approaches from anyone with inside information on all our cases including this one – we can be contacted through our secure and confidential reporting channel, which can be accessed via the SFO website.

Related Cases